Serotonin 5-HT2A / dopamine D1-D2 receptor

Class

Serotonin-dopamine activity modulator

This mechanism describes receptors that regulate brain signaling implicated in psychosis and mood disorders: the serotonin 5-HT2A receptor and the dopamine D1 and D2 receptors, all members of the G-protein-coupled receptor family that transmit chemical signals across neurons. Dopamine D2 receptor overactivity in certain brain circuits is linked to hallucinations and disordered thought, while serotonin signaling through 5-HT2A receptors modulates how much dopamine and glutamate are released in cortical and striatal regions. Drugs that block D2 receptors alone can relieve psychotic symptoms but often cause movement disorders and worsen mood or motivation. Combining D2 modulation with 5-HT2A antagonism, and in some cases D1 modulation, aims to preserve antipsychotic benefit while reducing motor side effects and better addressing mood and cognitive symptoms. This combined serotonin-dopamine profile underlies many so-called atypical antipsychotics, used broadly in schizophrenia, bipolar disorder, and as adjuncts in depression. The overall rationale is that balancing several receptor systems, rather than blocking one pathway in isolation, produces a more favorable ratio of symptom control to unwanted neurological and psychiatric side effects across diverse patient presentations.